FDA panel recommends Tysabri as Crohn's treatment
Stephen McGuire
August 01 2007
An FDA advisory panel voted 12-3 in favor of recommending Biogen IDEC and Elan's Tysabri for use in Crohn's disease ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Your message:
The e-mail address(es) that you supply to use this service will only be used to send the requested article.